久久无码中文字幕精品久久,国产电影一卡二卡三卡四卡,亚洲精选品质AV在线,heyzo无码中文字幕在线,AV在线人妻一区,国语对白乱妇激情视频,亚洲手机无码电影在线,无码不卡中文字幕,欧美一区人人躁

中文

Products

Location:Home > Products > GE
GE

Biacore T200、the versatile SPR system

Biacore T200 is a versatile system for high-quality characterization of molecular interactions, all the way from research to discovery and quality control
Share:

Back to product list
Detailed introduction

•       One platform for comprehensive characterization of molecular interactions in terms of kinetics, affinity, specificity, comparability, concentration, immunogenicity, and thermodynamics

•       Reliable ligand-binding assays, even for the most complex biologics

•       Confident selection and characterization of the smallest organic compounds to large multidomain proteins

•       Validated software meeting your regulatory expectations by supporting GxP procedures and 21 CFR Part 11 compliance

Fast, simple kinetic analysis

Biacore T200 software offers a range of tools for confident and reliable kinetic analyses. These analyses can be performed using a multicycle approach (many samples against one ligand or when different ligands are immobilized), or alternatively, using singlecycle kinetics (fast runs without regeneration).

 

Confident concentration analysis – with or without standards

Software-supported direct binding and inhibition assays enable measurement of active concentration. The precision and automation of the system generates highly reproducible data. Calibration-free concentration analysis (CFCA) is of great value when no satisfactory calibration standard is available.

 

Secure assays to meet regulatory needs

The widely adopted Biacore T200 offers reliable ligand-binding assays—as described in regulatory guidelines—to characterize and assess comparability, even for the most complex biologics. An optional GxP Package allows Biacore T200 to integrate seamlessly into GMP/GLP-regulated workflows.

 

Dedicated support for immunogenicity testing

The software provides dedicated tools for immunogenicity testing for confident detection and characterization of anti-drug antibodies (ADA) during preclinical and clinical development.